BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9485558)

  • 1. Evaluation of aminoglycoside pharmacokinetics in postpartum patients using Bayesian forecasting.
    Cropp CD; Davis GA; Ensom MH
    Ther Drug Monit; 1998 Feb; 20(1):68-72. PubMed ID: 9485558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian pharmacokinetics of gentamicin in a haemodialysis population.
    Vercaigne LM; Ariano RE; Zacharias JM
    Clin Pharmacokinet; 2004; 43(3):205-10. PubMed ID: 14871157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General versus subpopulation values in Bayesian prediction of aminoglycoside pharmacokinetics in hematology-oncology patients.
    Radomski KM; Davis GA; Chandler MH
    Am J Health Syst Pharm; 1997 Mar; 54(5):541-4. PubMed ID: 9066862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycoside pharmacokinetics in African-Americans with normal renal function.
    Oparaoji EC; Siram S; Elemihe U; Mezghebe HM; Cho T; Bashiri M; Piedrahita K; Pipalla RS
    J Clin Pharm Ther; 1998 Jun; 23(3):191-7. PubMed ID: 9831970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single daily dosing of gentamicin: pharmacokinetic comparison of two dosing methodologies for postpartum endometritis.
    Liu C; Abate B; Reyes M; Gonik B
    Infect Dis Obstet Gynecol; 1999; 7(3):133-7. PubMed ID: 10371471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gentamicin pharmacokinetics in postpartum women with endomyometritis.
    Munar MY; Lawson LA; Samuels P; Gibson GA
    DICP; 1991 Dec; 25(12):1306-9. PubMed ID: 1815422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian forecasting of aminoglycoside dosing requirements in obese patients: influence of subpopulation versus general population pharmacokinetic parameters as the internal estimates.
    McClellan SD; Farringer JA
    Ther Drug Monit; 1989; 11(4):431-6. PubMed ID: 2741192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gentamicin and tobramycin pharmacokinetics in pediatric bone marrow transplant patients.
    Jacobson PA; West NJ; Price J; Hutchinson RJ
    Ann Pharmacother; 1997 Oct; 31(10):1127-31. PubMed ID: 9337435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian forecasting of gentamicin pharmacokinetics in pediatric intensive care unit patients.
    Kraus DM; Dusik CM; Rodvold KA; Campbell MM; Kecskes SA
    Pediatr Infect Dis J; 1993 Sep; 12(9):713-8. PubMed ID: 8414796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglycoside forecasting in neutropenic patients with cancer.
    Kosirog JL; Rospond RM; Destache C; Hall P
    Clin Pharmacokinet; 1993 Jan; 24(1):79-87. PubMed ID: 8448975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of once-daily dosing of aminoglycosides through Bayesian simulation.
    Garrelts JC
    Pharmacotherapy; 1996; 16(2):286-94. PubMed ID: 8820474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of gentamicin concentrations in neonates and infants using a Bayesian pharmacokinetic model.
    Rodvold KA; Gentry CA; Plank GS; Kraus DM; Nickel E; Gross JR
    Dev Pharmacol Ther; 1993; 20(3-4):211-9. PubMed ID: 7828456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two methods to obtain a desired first isepamicin peak in intensive care patients.
    Fauvelle F; Coulaud JM; Lecointre K; Tardy D; Poussel JF; Trape G
    Fundam Clin Pharmacol; 2001 Apr; 15(2):151-6. PubMed ID: 11468025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE; King JH
    Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosing.
    Demczar DJ; Nafziger AN; Bertino JS
    Antimicrob Agents Chemother; 1997 May; 41(5):1115-9. PubMed ID: 9145878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily.
    Kirkpatrick CM; Duffull SB; Begg EJ
    Br J Clin Pharmacol; 1999 Jun; 47(6):637-43. PubMed ID: 10383541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Sawchuk-Zaske and Bayesian forecasting for aminoglycosides in seriously ill patients.
    Denaro CP; Ravenscroft PJ
    Br J Clin Pharmacol; 1989 Jul; 28(1):37-44. PubMed ID: 2775614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens.
    Barletta JF; Johnson SB; Nix DE; Nix LC; Erstad BL
    J Trauma; 2000 Nov; 49(5):869-72. PubMed ID: 11086778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian forecasting of serum gentamicin concentrations in intensive care patients.
    Rodvold KA; Pryka RD; Kuehl PG; Blum RA; Donahue P
    Clin Pharmacokinet; 1990 May; 18(5):409-18. PubMed ID: 2335046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulated Comparison of a Bayesian Clinical Decision Support System Versus Standard of Care For Achieving Gentamicin Pharmacokinetic Targets in Neonates.
    Yu CZ; Myers SR; Faldasz JD
    Pediatr Infect Dis J; 2020 Apr; 39(4):313-317. PubMed ID: 32032171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.